Key result
Transcatheter pulmonary valve replacement showed short and medium-term outcomes comparable to surgical replacement, with 60% freedom from Melody valve stent fracture at 30 months.
Why the study?
What are the current outcomes, complications, and challenges associated with transcatheter pulmonary valve replacement?
What are the current outcomes, complications, and challenges associated with transcatheter pulmonary valve replacement?
Transcatheter pulmonary valve replacement offers comparable or superior short- to medium-term outcomes compared to surgery, though native RVOT anatomy and long-term durability remain challenges.
Answers are grounded in this paper and cite their sources.
Only two valves approved for transcatheter pulmonary valve replacement; leaves open need for expanded options and comparative data.
BACKGROUND: The number of patients undergoing transcatheter pulmonary valve replacement has been steadily increasing, resulting in many research projects focusing on this patient population. This has highlighted the need to summarize the currently available data. METHODS: A review of the literature was conducted and the results summarized. RESULTS: At present, the two commercially available valves approved for transcatheter pulmonary valve replacement include the Edwards Sapien valve and the Medtronic Melody valve. More data has been published relating to the Melody valve; this included the incidence of coronary anatomy prohibiting valve implantation of 5%, an incidence of conduit disruption of 6%, and freedom from stent fracture of the Melody valve stent of 60% at 30 months. Short and medium term outcomes seem to be comparable if not superior to surgical valve replacement, but long-term data is still lacking. There may also be a cost benefit with transcatheter valve implantation when compared to surgical pulmonary valve replacement. CONCLUSIONS: Transcatheter pulmonary valve replacement is here to stay. The main challenge of treating patients with a native right ventricular outflow tract still needs to be addressed and device development efforts centered in this area.
No takes yet. Share an insight, caveat, or question.
Holzer et al. (2015) conducted a review in Patients undergoing transcatheter pulmonary valve replacement. Transcatheter pulmonary valve replacement vs. Surgical pulmonary valve replacement was evaluated. Transcatheter pulmonary valve replacement showed short and medium-term outcomes comparable to surgical replacement, with 60% freedom from Melody valve stent fracture at 30 months.
Synapse has enriched 10 related papers. Consider them for comparative context: